Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Other Working Capital Changes (2017 - 2025)

Organogenesis Holdings has reported Other Working Capital Changes over the past 9 years, most recently at -$3.1 million for Q4 2025.

  • Quarterly results put Other Working Capital Changes at -$3.1 million for Q4 2025, down 107.25% from a year ago — trailing twelve months through Dec 2025 was $183000.0 (down 92.82% YoY), and the annual figure for FY2025 was $183000.0, down 92.82%.
  • Other Working Capital Changes for Q4 2025 was -$3.1 million at Organogenesis Holdings, up from -$9.6 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for ORGO hit a ceiling of $7.8 million in Q2 2025 and a floor of -$9.6 million in Q3 2025.
  • Median Other Working Capital Changes over the past 5 years was $205637.5 (2022), compared with a mean of $583713.8.
  • Biggest five-year swings in Other Working Capital Changes: tumbled 549.57% in 2021 and later soared 11103.72% in 2024.
  • Organogenesis Holdings' Other Working Capital Changes stood at -$64000.0 in 2021, then surged by 692.19% to $379000.0 in 2022, then surged by 1383.91% to $5.6 million in 2023, then plummeted by 126.72% to -$1.5 million in 2024, then plummeted by 107.25% to -$3.1 million in 2025.
  • The last three reported values for Other Working Capital Changes were -$3.1 million (Q4 2025), -$9.6 million (Q3 2025), and $7.8 million (Q2 2025) per Business Quant data.